Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment. It also provides prefilled syringes and pre-filled flush syringes; blood collection and blood glucose testing devices; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, and open and minimally invasive surgical equipment. In addition, the company engages in the production and sale of orthopedic devices; tumor and blood vessel interventional instruments; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and type I, type II, and type III medical devices. Further, it is involved in the finance leasing and factoring business; wholesale of type I medical devices, surgical devices, and other disposal medical products; provision of asset management, enterprise consulting, enterprise management advisory services, as well as logistics and storage services, as well as export its products. The company offers its products under the Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing brands. It serves hospitals, blood stations, and other medical units; and distributors. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
Shandong Weigao Medical Polymer Dividend Announcement
• Shandong Weigao Medical Polymer announced a semi annually dividend of HK$0.09 per ordinary share which will be made payable on 2024-11-22. Ex dividend date: 2024-10-18
• Shandong Weigao Medical Polymer annual dividend for 2024 was HK$0.20
• Shandong Weigao Medical Polymer annual dividend for 2023 was HK$0.17
• Shandong Weigao Medical Polymer's trailing twelve-month (TTM) dividend yield is 3.61%
• Shandong Weigao Medical Polymer's payout ratio for the trailing twelve months (TTM) is 52.22%
• Shandong Weigao Medical Polymer's dividend growth over the last five years (2018-2023) was 0.86% year
• Shandong Weigao Medical Polymer's dividend growth over the last ten years (2013-2023) was 10.42% year
Shandong Weigao Medical Polymer Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-10-18 | HK$0.09 | semi annually | 2024-11-22 |
2024-06-03 | HK$0.10 | semi annually | 2024-07-12 |
2023-10-19 | HK$0.08 | semi annually | 2023-11-24 |
2023-06-01 | HK$0.09 | semi annually | 2023-07-14 |
2022-10-03 | HK$0.10 | semi annually | 2022-11-11 |
2022-06-09 | HK$0.08 | semi annually | 2022-07-15 |
2021-09-29 | HK$0.09 | semi annually | 2021-11-05 |
2021-05-27 | HK$0.08 | semi annually | 2021-07-05 |
2020-10-16 | HK$0.07 | semi annually | 2020-11-20 |
2020-07-27 | HK$0.07 | semi annually | 2020-08-31 |
2019-11-21 | HK$0.07 | semi annually | 2019-12-23 |
2019-07-05 | HK$0.06 | semi annually | 2019-08-15 |
2018-12-11 | HK$0.06 | semi annually | 2019-01-18 |
2018-11-09 | HK$0.05 | semi annually | |
2018-06-21 | HK$0.06 | semi annually | 2018-07-27 |
2017-10-26 | HK$0.05 | semi annually | 2017-12-08 |
2017-06-15 | HK$0.05 | semi annually | 2017-07-21 |
2016-11-17 | HK$0.05 | semi annually | 2016-12-29 |
2016-06-16 | HK$0.04 | semi annually | 2016-07-29 |
2015-10-23 | HK$0.05 | semi annually | 2015-12-11 |
2015-06-17 | HK$0.04 | semi annually | 2015-07-31 |
2014-11-20 | HK$0.03 | semi annually | 2014-12-30 |
2014-06-05 | HK$0.03 | semi annually | 2014-07-11 |
2013-11-19 | HK$0.03 | semi annually | 2013-12-23 |
2013-06-06 | HK$0.03 | semi annually | 2013-07-05 |
Shandong Weigao Medical Polymer Dividend per year
Shandong Weigao Medical Polymer Dividend growth
Shandong Weigao Medical Polymer Dividend Yield
Shandong Weigao Medical Polymer current trailing twelve-month (TTM) dividend yield is 3.61%. Interested in purchasing Shandong Weigao Medical Polymer stock? Use our calculator to estimate your expected dividend yield:
Shandong Weigao Medical Polymer Financial Ratios
Shandong Weigao Medical Polymer Dividend FAQ
Other factors to consider when evaluating Shandong Weigao Medical Polymer as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Shandong Weigao Medical Polymer stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Shandong Weigao Medical Polymer's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Shandong Weigao Medical Polymer publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Shandong Weigao Medical Polymer distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Shandong Weigao Medical Polymer are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Shandong Weigao Medical Polymer sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Shandong Weigao Medical Polymer distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Shandong Weigao Medical Polymer declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Shandong Weigao Medical Polymer's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Shandong Weigao Medical Polymer's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.